Evidence map›Paper›PMID 31279606›Full record

ArticleCell chemical biology2019

Discovery of a Novel DNA Gyrase-Targeting Antibiotic through the Chemical Perturbation of Streptomyces venezuelae Sporulation.

Scott McAuley, Alan Huynh, Alison Howells, Chris Walpole, Anthony Maxwell, Justin R Nodwell

Open access · hybridAbstract read
In one paragraph

Article in Cell chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Catalytic evaluation andRSC advances · 2023
    Article
  5. Article
  6. La-Doped CeOACS omega · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Prodiginines Postpone the Onset of Sporulation inAntibiotics (Basel, Switzerland) · 2020
    Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Scott McAuleyDepartment of Biochemistry, University of Toronto, Toronto, ON M5G 1M1, Canada.
Alan HuynhDepartment of Biochemistry, University of Toronto, Toronto, ON M5G 1M1, Canada.
Alison HowellsInspiralis Ltd., Innovation Centre, Norwich Research Park, Colney Lane, Norwich NR4 7UH, UK.
Chris WalpoleStructural Genomics Consortium, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
Anthony MaxwellDepartment of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK.
Justin R NodwellDepartment of Biochemistry, University of Toronto, Toronto, ON M5G 1M1, Canada. Electronic address: justin.nodwell@utoronto.ca.
University of Toronto · CANorwich Research Park · GBStructural Genomics Consortium · CA

Funding

Biotechnology and Biological Sciences Research Council BB/J004561/1Biotechnology and Biological Sciences Research Council BB/P012523/1Biotechnology and Biological Sciences Research Council BBS/E/J/00000201CIHR MOP-133636Wellcome TrustWellcome Trust 110072/Z/15/Z
6 · The paper itself

Abstract

Common approaches to antibiotic discovery include small-molecule screens for growth inhibition in target pathogens and screens for inhibitors of purified enzymes. These approaches have a shared intent of seeking to directly target a vital Achilles heel in a pathogen of interest. Here, we report the first screen against a sporulation pathway in a non-pathogenic bacterium as a means of discovering novel antibiotics-this effort has resulted in two important discoveries. First, we show that the sporulation program of Streptomyces venezuelae is exquisitely sensitive to numerous forms of DNA damage. Second, we have identified a DNA gyrase inhibitor. This molecule, EN-7, is active against pathogenic species that are resistant to ciprofloxacin and other clinically important antibiotics. We suggest that this strategy could be applied to other morphogenetic pathways in prokaryotes or eukaryotes as a means of identifying novel chemical matter having scientific and clinical utility.

Indexed as

Anti-Bacterial AgentsDNA GyraseDrug DiscoveryMicrobial Sensitivity TestsSpores, BacterialStreptomycesTopoisomerase II InhibitorsAnti-Bacterial AgentsDNA GyraseTopoisomerase II Inhibitorsantibioticantibiotic resistancechemical screeningdiscoveryDNA gyrase inhibitorssporulation inhibitorstarget identification

Identifiers

PMID31279606
PMCPMC6856721
OpenAlexW2953803755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.